Table 2.
Groups | Db/db | Db/db Apocynin | db/db | db/db Apocynin |
---|---|---|---|---|
6 weeks | 100 ± 4 | 101 ± 3 | 114 ± 6# | 93 ± 4* |
12 weeks | 100 ± 3 | 102 ± 5 | 134 ± 7# | 109 ± 6* |
| ||||
Db/db | Db/db Apocynin rotenone | db/db | db/db Apocynin rotenone | |
| ||||
18 weeks | 116 ± 8# | 97 ± 5& | 151 ± 12# | 110 ± 9* |
| ||||
Db/db | Db/db Rotenone | db/db | db/db Rotenone | |
| ||||
24 weeks | 127 ± 11# | 109 ± 6& | 158 ± 17# | 116 ± 8* |
O2.− production was higher in isolated coronary arteries from db/db mice Vs. Db/db mice aged 6, 12, 18 and 24 weeks. Administration of NAD(P)H oxidase inhibitor apocynin reduced the production of O2.− in db/db mice at 6 and 12 weeks (n = 9); administration of apocynin and mitochondria respiratory chain inhibitor rotenone reduced the production of O2.− in Db/db and db/db mice at 18 weeks (n = 9); and administration of rotenone reduced the production of O2.− in Db/db and db/db mice at 24 weeks (n = 9)
Values are mean ± SE.
P < 0.05 Vs. Db/db mice;
P < 0.05 Vs. Db/db mice (18 and 24 weeks); and
P < 0.05 Vs. db/db